Action 002412 HUNAN HANSEN PHARMACEUTICAL CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Hunan Hansen Pharmaceutical Co., Ltd.

Actions

002412

CNE100000PK2

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 17/05/2024 		Varia. 5j. Varia. 1 janv.
6,03 CNY +0,50% Graphique intraday de Hunan Hansen Pharmaceutical Co., Ltd. -0,99% -11,06%
26/04 Hunan Hansen Pharmaceutical Co. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
26/04 Hunan Hansen Pharmaceutical Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Hansen Pharmaceutical Gets Nod to Amend Information for Isoniazid Tablets
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Hunan Hansen Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 20, 2023
Hunan Hansen Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2022
Hunan Hansen Pharmaceutical Co., Ltd. Announces Board Appointments
Hansen Pharma's Iohexol Injection Passes Drug Regulator's Evaluation
Hunan Hansen Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2022
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Hansen Health Industry Co., Ltd. announced that it expects to receive CNY 40 million in funding from Hunan Hansen Pharmaceutical Co., Ltd.
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Hunan Hansen Pharmaceutical Co., Ltd. Approves Cash Dividend for 2020
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 002412
  4. Actualités Hunan Hansen Pharmaceutical Co., Ltd.
  5. Autres langues